Dataset from A Randomized Double-Blind Phase 4 Study to Evaluate the Safety and Proportion of Subjects With Fistula Healing in 2 Dose Regimens of Entyvio (Vedolizumab IV) in the Treatment of Fistulizing Crohn's Disease (ENTERPRISE)
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/00007365
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the percentage of participants with perianal fistula
healing at Week 30 in 2 different dose regimens of vedolizumab intravenous (IV) 300 milligram
(mg) in participants with fistulizing Crohn's disease (CD).
创建时间：
2025-10-01
